KMAP BULLETIN: Rate Changes for Physician-Administered Drugs – October 2026
Act
by Sep 30, 2026
Effective date
Oct 1, 2026
Identified
Sep 3, 2026
Summary
Effective October 1, 2026, KMAP will update Medicaid reimbursement rates for physician-administered drugs (PADs) by aligning pure HCPCS codes with CMS Medicare Part B rates. Unlisted procedure code drugs will continue using WAC-based rates, while High Dollar Rare Disease Drugs follow existing MCO guidelines. LARC product price changes will be retroactive to their effective dates.
Get alerts when payers change rules like this one
We check Kansas Medicaid (KanCare) and other payers every day and email you when a change matches your specialty and state.
01Billing team must obtain updated KMAP fee schedules for all physician-administered drug HCPCS codes from the KMAP portal and load them into the billing system.
02Update billing software to apply the new Medicare Part B-aligned rates to all claims with dates of service on or after October 1, 2026.
03Verify that unlisted procedure codes continue to use WAC-based pricing and that HD RDD codes reference General Bulletin 25274 for MCO pricing.
04Monitor the KanCare Open Claims Resolution Log on the KMAP Bulletins page for MCO-specific implementation dates and any required reprocessing timelines.
05Communicate effective dates to all providers administering PADs.
If missed: Failure to implement updated rates may result in claim denials or overpayment recovery.
Original notice
KMAP BULLETIN: Rate Changes for Physician-Administered Drugs – October 2026
portal.kmap-state-ks.us · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.